Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hammes, HP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stracke, H; Hammes, HP; Werkmann, D; Mavrakis, K; Bitsch, L; Netzel, M; Geyer, L; Kopcke, W; Sauerland, C; Bretzel, RG; Federlin, KF
      Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    2. Riecke, B; Chavakis, E; Bretzel, RG; Linn, T; Preissner, KT; Brownlee, M; Hammes, HP
      Topical application of integrin antagonists inhibits proliferative retinopathy

      HORMONE AND METABOLIC RESEARCH
    3. Brandhorst, D; Hammes, HP; Brandhorst, H; Zwolinski, A; Nahidi, F; Alt, A; Bretzel, RG
      Pretransplant induction of HSP-70 in isolated adult pig islets decreases early islet xenograft survival

      CELL TRANSPLANTATION
    4. Nishikawa, T; Edelstein, D; Du, XL; Yamagishi, S; Matsumura, T; Kaneda, Y; Yorek, MA; Beebe, D; Oates, PJ; Hammes, HP; Giardino, I; Brownlee, M
      Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

      NATURE
    5. Spranger, J; Hammes, HP; Preissner, KT; Schatz, H; Pfeiffer, AFH
      Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagolation

      DIABETOLOGIA
    6. Schmidt, KG; von Ruckmann, A; Kemkes-Matthes, B; Hammes, HP
      Ocular pulse amplitude in diabetes mellitus

      BRITISH JOURNAL OF OPHTHALMOLOGY
    7. Chavakis, T; Kanse, SM; Lupu, F; Hammes, HP; Muller-Esterl, W; Pixley, RA; Colman, RW; Preissner, KT
      Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions

      BLOOD
    8. Ali, SS; Becker, L; Flockenhaus, S; Hammes, HP
      Neovascularisation in the murine model of "retinopathy of prematurity"

      SCANNING
    9. Hammes, HP; Hoerauf, H; Alt, A; Schleicher, E; Clausen, JT; Bretzel, RG; Laqua, H
      N-epsilon(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    10. Hammes, HP; Alt, A; Niwa, T; Clausen, JT; Bretzel, RG; Brownlee, M; Schleicher, ED
      Differential accumulation of advanced glycation end products in the courseof diabetic retinopathy

      DIABETOLOGIA
    11. Hammes, HP; Brownlee, M; Lin, J; Schleicher, E; Bretzel, RG
      Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N-epsilon-(carboxymethyl) lysine independently ofglycohaemoglobin concentrations

      DIABETOLOGIA
    12. HAMMES HP; WELLENSIEK B; KLOTING I; SICKEL E; BRETZEL RG; BROWNLEE M
      THE RELATIONSHIP OF GLYCEMIC LEVEL TO ADVANCED GLYCATION END-PRODUCT (AGE) ACCUMULATION AND RETINAL PATHOLOGY IN THE SPONTANEOUS DIABETIC HAMSTER

      Diabetologia
    13. HAMMES HP; BRETZEL RG; FEDERLIN K; HORIUCHI S; NIWA T; STRACKE H
      BENFOTIAMIN INHIBITS THE FORMATION OF ADVANCED GLYCATION END-PRODUCTSIN DIABETIC RATS

      Diabetologia
    14. HAMMES HP; LIN JH; BRETZEL RG; BROWNLEE M; BREIER G
      UP-REGULATION OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR SYSTEM IN EXPERIMENTAL BACKGROUND DIABETIC-RETINOPATHY OF THE RAT

      Diabetes
    15. BECKER P; SCHMIDT KG; VONRUCKMANN A; HAMMES HP; KEMKESMATTHES B; PILLUNAT LE
      OCULAR PULSE AMPLITUDE IN DIABETIC-PATIENTS

      Investigative ophthalmology & visual science
    16. PREISSNER KT; KANSE SM; HAMMES HP
      INTEGRIN CHATTER AND VASCULAR FUNCTION IN DIABETIC-RETINOPATHY

      Hormone and Metabolic Research
    17. HAMMES HP; BARTMANN A; ENGEL L; WULFROTH P
      ANTIOXIDANT TREATMENT OF EXPERIMENTAL DIABETIC-RETINOPATHY IN RATS WITH NICANARTINE

      Diabetologia
    18. HAMMES HP; BROWNLEE M; JONCZYK A; SUTTER A; PREISSNER KT
      SUBCUTANEOUS INJECTION OF A CYCLIC PEPTIDE ANTAGONIST OF VITRONECTIN RECEPTOR-TYPE INTEGRINS INHIBITS RETINAL NEOVASCULARIZATION (VOL 2, PG529, 1996)

      Nature medicine
    19. HAMMES HP; BROWNLEE M; JONCZYK A; SUTTER A; PREISSNER KT
      SUBCUTANEOUS INJECTION OF A CYCLIC PEPTIDE ANTAGONIST OF VITRONECTIN RECEPTOR-TYPE INTEGRINS INHIBITS RETINAL NEOVASCULARIZATION

      Nature medicine
    20. HAMMES HP; WEISS A; HESS S; ARAKI N; HORIUCHI S; BROWNLEE M; PREISSNER KT
      MODIFICATION OF VITRONECTIN BY ADVANCED GLYCATION ALTERS FUNCTIONAL-PROPERTIES IN-VITRO AND IN THE DIABETIC RETINA

      Laboratory investigation
    21. HAMMES HP; WEISS A; FUHRER D; KRAMER HJ; PAPAVASSILIS C; GRIMMINGER F
      ACCELERATION OF EXPERIMENTAL DIABETIC-RETINOPATHY IN THE RAT BY OMEGA-3-FATTY-ACIDS

      Diabetologia
    22. HAMMES HP; FEDEROFF HJ; BROWNLEE M
      NERVE GROWTH-FACTOR PREVENTS BOTH NEURORETINAL PROGRAMMED CELL-DEATH AND CAPILLARY PATHOLOGY IN EXPERIMENTAL DIABETES

      Molecular medicine
    23. HAMMES HP; WELLENSIEK B; KLOTING I; SICKEL E; BROWNLEE M
      RETINAL AGE-ACCUMULATION AND VASCULAR CHANGES IN THE CHINESE-HAMSTER - EFFECTS OF GRADUAL HYPERGLYCEMIA

      Investigative ophthalmology & visual science
    24. HAMMES HP; STRODTER D; WEISS A; BRETZEL RG; FEDERLIN K; BROWNLEE M
      SECONDARY INTERVENTION WITH AMINOGUANIDINE RETARDS THE PROGRESSION OFDIABETIC-RETINOPATHY IN THE RAT MODEL

      Diabetologia
    25. HAMMES HP; ALI SS; UHLMANN M; WEISS A; FEDERLIN K; GEISEN K; BROWNLEE M
      AMINOGUANIDINE DOES NOT INHIBIT THE INITIAL PHASE OF EXPERIMENTAL DIABETIC-RETINOPATHY IN RATS

      Diabetologia
    26. HAMMES HP; FEDEROFF HJ; BROWNLEE M
      THE EFFECT OF EXPERIMENTAL DIABETES ON RETINAL GFAP AND NGF PERMEATION

      Investigative ophthalmology & visual science
    27. HAMMES HP; MASER E; STRACKE H; BRETZEL RG
      PREVALENCE OF DIABETIC COMPLICATIONS OF T YPE-I AND TYPE-II DIABETES-MELLITUS - AN ANALYSIS OF 575 DIABETICS RECEIVING OUTPATIENT CARE

      Die medizinische Welt
    28. HAMMES HP; BROWNLEE M; EDELSTEIN D; SALECK M; MARTIN S; FEDERLIN K
      AMINOGUANIDINE INHIBITS THE DEVELOPMENT OF ACCELERATED DIABETIC-RETINOPATHY IN THE SPONTANEOUS HYPERTENSIVE RAT

      Diabetologia
    29. HAMMES HP; PREISSNER K; EPPINGERALBRECHT M; BENNER K; WEISS A; BROWNLEE M
      VITRONECTIN FUNCTIONAL-PROPERTIES ARE ALTERED BY ADVANCED GLYCATION ENDPRODUCTS (AGES)

      Diabetes
    30. PREISSNER KT; KOST C; ROSENBLATT S; DEBOER H; HAMMES HP; PANNEKOEK H
      THE ROLE OF FIBRINOLYSIS IN THE CROSS-TALKS AMONG VESSEL WALL COMPONENTS - THE VITRONECTIN-PAI-1 AXIS

      Fibrinolysis
    31. HAMMES HP; KLINZING I; WIEGAND S; BRETZEL RG; COHEN AM; FEDERLIN K
      ISLET TRANSPLANTATION INHIBITS DIABETIC-RETINOPATHY IN THE SUCROSE-FED DIABETIC COHEN RAT

      Investigative ophthalmology & visual science
    32. HAMMES HP; UHLMANN M; WEISS A; FEDERLIN K; GEISEN K; BROWNLEE M
      A TIME-COURSE STUDY WITH AMINOGUANIDINE IN EXPERIMENTAL DIABETIC-RETINOPATHY

      Diabetologia
    33. HAMMES HP; FEDEROFF H; BROWNLEE M
      THE EFFECT OF NERVE GROWTH-FACTOR (NGF) ON EXPERIMENTAL DIABETIC-RETINOPATHY

      Diabetes


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 05:46:09